The transcriptomic signature of myostatin inhibitory influence on the differentiation of mouse C2C12 myoblasts

Journal title

Polish Journal of Veterinary Sciences




No 4


Divisions of PAS

Nauki Biologiczne i Rolnicze


Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn




DOI: 10.2478/v10181-011-0095-7 ; ISSN 1505-1773


Polish Journal of Veterinary Sciences; 2011; No 4


Berridge M. (2003), Calcium signalling: dynamics, homeostasis and remodelling, Nat Rev Mol Cell Biol, 4, 517, ; Bachinski L. (2010), Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders, Muscle Nerve, 42, 856, ; Budasz-Świderska M. (2005), Transforming Growth Factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts, J Physiol Pharmacol, 56, 195. ; Charge S. (2004), Cellular and molecular regulation of muscle regeneration, Physiol Rev, 84, 209, ; Diel P. (2008), C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression, J Mol Endocrinol, 40, 231, ; Guo T. (2009), Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity, PLoS One, 4. ; Ho C. (2010), Hypertrophic cardiomyopathy, Heart Fail Clin, 6, 141, ; Janot M. (2009), Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates, BMC Genomics, 10, 483, ; Isenberg G. (2004), Ca<sup>2+</sup> control of transcription: can we extrapolate signaling cascades from neurons to vascular smooth muscle cells?, Circ Res, 94, 1276, ; Joulia D. (2003), Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin, Exp Cell Res, 286, 263, ; Konno T. (2010), Heterogeneous myocyte enhancer factor- 2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy, Proc Natl Acad Sci USA, 107, 18097, ; Langley B. (2002), Myostatin inhibits myoblast differentiation by down-regulating MyoD expression, J Biol Chem, 277, 49831, ; Lee S. (2001), Regulation of myostatin activity and muscle growth, Proc Natl Acad Sci USA, 98, 9306, ; McPherron A. (1997), Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member, Nature, 387, 83, ; McPherron A. (2002), Suppression of body fat accumulation in myostatin-deficient mice, J Clin Invest, 109, 595. ; Morimoto S. (2008), Sarcomeric proteins and inherited cardiomyopathies, Cardiovasc Res, 77, 659, ; Mootha V. (2003), PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, ; Ostrander E. (2009), Genetics of athletic performance, Annu Rev Genomics Hum Genet, 10, 407, ; Sadkowski T. (2009), Comparison of skeletal muscle transcriptional profiles in dairy and beef breeds bulls, J Appl Genet, 50, 109, ; Sadkowski T. (2008), Gene expression profiling in skeletal muscle of Holstein-Friesian bulls with single-nucleotide polymorphism in the myostatin gene 5'-flanking region, J Appl Genet, 49, 237, ; Sato F. (2006), Gene silencing of myostatin in differentiation of chicken embryonic myoblasts by small interfering RNA, Am J Physiol Cell Physiol, 291. ; Shemyakin A. (2010), Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro, J Clin Endocrinol Metab, 95, 2359, ; Shen X. (2003), Genome-wide examination of myoblast cell cycle withdrawal during differentiation, Dev Dyn, 226, 128, ; Shi X. (2006), Muscle stem cells in development, regeneration, and disease, Genes Dev, 20, 1692, ; Thomas M. (2000), Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation, J Biol Chem, 275, 40235, ; Wagers A. (2005), Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis, Cell, 122, 659, ; Wicik Z. (2010), Transcriptional pattern of TGF-β1 inhibitory effect on mouse C2C12 myoblasts differentiation, Pol J Vet Sci, 13, 629.